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Telomeres in ICF syndrome cells are vulnerable to
DNA damage due to elevated DNA:RNA hybrids
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Claire Francastel3, Guillaume Velasco3, Fre´de´ric Che´din2 & Sara Selig1
DNA:RNA hybrids, nucleic acid structures with diverse physiological functions, can disrupt
genome integrity when dysregulated. Human telomeres were shown to form hybrids with the
lncRNA TERRA, yet the formation and distribution of these hybrids among telomeres, their
regulation and their cellular effects remain elusive. Here we predict and confirm in several
human cell types that DNA:RNA hybrids form at many subtelomeric and telomeric regions.
We demonstrate that ICF syndrome cells, which exhibit short telomeres and elevated TERRA
levels, are enriched for hybrids at telomeric regions throughout the cell cycle. Telomeric
hybrids are associated with high levels of DNA damage at chromosome ends in ICF cells,
which are significantly reduced with overexpression of RNase H1. Our findings suggest that
abnormally high TERRA levels in ICF syndrome lead to accumulation of telomeric hybrids
that, in turn, can result in telomeric dysfunction.
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T
elomeres are nucleoprotein complexes that maintain the
integrity and stability of eukaryotic chromosome ends1,2.
T-loop formation, binding of shelterin and non-shelterin
proteins and a unique chromatin structure, all protect the
chromosome ends from deleterious events such as degradation
and end-to-end fusions3. Human telomeres undergo gradual
attrition with each cell division, and when they reach a critical
length, telomere shortening elicits replicative senescence4, with
only a few short telomeres being sufficient to initiate this
response5,6. In vertebrates, the telomeric DNA consists of a
(TTAGGG)n repeat. Subtelomeres, the regions immediately
proximal to telomeres, contain CpG-rich repetitive sequences,
telomere-like repeats and families of larger repeats7,8 and are
packaged together with the telomeres as heterochromatin that
assists in the stabilization of the chromosome ends9. Although
sharing many characteristics, different human subtelomeres vary
in size, sequence content and organization10. The transcription of
telomeric repeat-containing RNA (TERRA), a long non-coding
RNA produced by RNA polymerase II (refs 11,12), initiates
within the subtelomeres at close proximity to the telomere tract
and utilizes the telomeric C-rich leading strand as its template7
(reviewed in ref. 13). TERRA has been implicated in numerous
telomeric roles, such as regulation of telomere length, replication
and heterochromatinization14–19 (reviewed in refs 2,13). Evidence
is emerging that the function and regulation of TERRA are
telomere state dependent such that telomere length, telomerase
expression and ALT pathway activity can influence the role that
TERRA has at telomeres (reviewed in ref. 20).
R-loops, three-stranded nucleic acid structures that consist of a
DNA:RNA hybrid and a displaced single-stranded DNA loop21,
are predisposed by strand asymmetry in the distribution of
guanines and cytosines, termed GC-skewing. These structures
form mainly co-transcriptionally when positive GC skew is
present such that DNA:RNA hybrids form between the G-rich
RNA strand and the C-rich complementary DNA strand22.
Although various studies indicate that DNA:RNA hybrids have a
positive effect on gene transcription and are beneficial to the
cell22–25, these structures have also been shown to mediate
genome instability and replication stress26. R-loops have been
implicated in human diseases, including trinucleotide expansion
diseases, neurological diseases and cancer (reviewed in ref. 27).
Telomeric DNA and TERRA transcripts are predicted to form
hybrids, with the G-rich (UUAGGG)n TERRA transcript
annealing to the C-rich (CCCTAA)n DNA template. Indeed,
recent studies support the existence of such hybrids at
telomeres in S. cerevisiae (whose telomeres are comprised of a
different G-rich repeat)14,28,29 and suggest that, in the absence of
a telomere-maintenance mechanism, TERRA-telomeric DNA
hybrids may promote accelerated telomere loss in cis14. In
addition, telomeric DNA:RNA hybrids were found in various
human cancer cells, both telomerase-positive and ALT cancerous
cells30. In the latter, DNA:RNA hybrids were suggested to have a
role in facilitating telomere recombination.
ICF (Immunodeficiency, Centromeric instability and Facial
anomalies) syndrome type I is a rare autosomal-recessive
syndrome, caused by hypomorphic mutations in the DNMT3B
gene31,32, the major DNA methyltransferase involved in de novo
methylation of repetitive sequences in mammalian cells during
development32. Subtelomeres, as other repetitive sequences,
are severely hypomethylated in ICF type I syndrome cells33–35.
We detected accelerated telomere shortening and significant
telomere loss, premature replicative senescence and significantly
elevated levels of TERRA transcripts in both ICF fibroblast
and lymphoblastoid cells (LCLs)33,35. Although it was
proposed that TERRA has a causative role in the generation
of telomeric abnormalities in ICF syndrome14,17,33–37, the
underlying mechanism by which this occurs is as yet
unclear.
Here we further investigate the occurrence of human telomeric
hybrids in various cell types. Furthermore, we address the
question of whether all telomeres are equally competent in
generating these hybrids and whether the subtelomeric regions
may affect this capacity. Our findings establish that telomeric
DNA:RNA hybrids occur also in primary human cells and that
subtelomeric sequences have an effect on generation of telomeric
hybrids. We demonstrate that elevated TERRA levels are
associated with higher levels of telomeric hybrids in ICF
syndrome and suggest a role for these DNA:RNA hybrids in
promoting damage and instability at telomeric regions in this
disease.
Results
Human subtelomeres are predicted to form DNA:RNA hybrids.
Human telomere-hexameric (TTAGGG)n repeats are predicted to
form DNA:RNA hybrids, with the C-rich template annealing to
the G-rich TERRA transcript. We validated this capacity in vitro
and demonstrated, as in a previous study30, that these hybrids are
formed only in a specific direction and are sensitive to RNase H,
an enzyme that specifically degrades RNA strands within
DNA:RNA hybrids (Supplementary Fig. 1).
The majority of TERRA transcripts initiate at the last few
hundred base-pairs (bps) of the subtelomeric region7, although
some TERRA species may start 5–10 kb upstream of the telomere
tract38. As most DNA:RNA hybrids are assumed to form
co-transcriptionally22,39, we speculated that subtelomeric
sequences might facilitate the formation of telomeric hybrids.
To test this hypothesis, we first analysed the sequence of the distal
2 kb region adjacent to the telomere tract at both chromosome
ends for CpG density, GC content and GC skew23. Regions with a
strong GC skew downstream of the TERRA promoter may
be prone to DNA:RNA hybrid formation. For this analysis,
we utilized the previously described subtelomeric sequences8,10,
focussing on high-confidence subtelomeric regions whose
sequence is available in the UCSC GRCh38/hg38 release with a
clearly defined telomeric region or at least three consecutive
TTAGGG repeats at the 30 end. These subtelomeric regions were
overlaid with the predicted TERRA promoters and transcription
start sites (TSSs), as determined by the Genomatix software40.
Most human subtelomeric regions exhibit high CpG density
and GC content in regions corresponding to the predicted
promoters for TERRA (Fig. 1a), thus closely resembling CpG
island promoters. This is consistent with a similar analysis of a
subgroup of TERRA promoters7 and reinforced by the findings
that TERRA transcribing telomeres show higher GC content in
comparison to the non-transcribing ones38. Examination of GC
skew revealed that its levels are variable over the entire 2 kb
region. However, a substantial number, but not all, of the
analysed subtelomeres possess positive GC skew in the region
located immediately downstream of the predicted TERRA TSSs
(Fig. 1a). Thus a subgroup of subtelomeres appears prone to form
DNA:RNA hybrids at the end of chromosome arms, which could
then extend into the neighbouring telomeric regions.
Subtelomeric DNA:RNA hybrids form in human cell lines. The
analysis above prompted us to test whether DNA:RNA hybrids
indeed form at distal human subtelomeric regions in vivo.
Quantification of DNA:RNA hybrids is classically carried out by
DNA:RNA hybrid immunoprecipitation (DRIP), a procedure that
involves immunoprecipitation of these hybrids with the S9.6
antibody22, and subsequently quantitative PCR (qPCR) or
sequencing. For this, we analysed available genome-wide DRIP-
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Figure 1 | Sequence characteristics and potential for DNA:RNA hybrid formation in human distal subtelomeres. (a) 2 kb distal subtelomeric regions
immediately adjacent to the telomere repeat tract were analysed for CpG density, GC content and GC skew over tiled overlapping 200bp windows. The value
for each window is depicted using a colour heatmap, as indicated below; each tick mark corresponds to a window. The analysed subtelomeres, indicated on the
right, are clustered by the GC skew downstream of the annotated TERRA promoter, when available (grey: no annotation). Predicted Pol2 promoters and putative
TSSs are indicated by boxes and black vertical lines, respectively. (b) DRIP-seq signal over each subtelomeric region is indicated by a colour heatmap reflecting
signal enrichment over input for each 2 kb window (colour scheme is indicated at the right). A, B, and C refer to three distinct DRIP-seq datasets in human
fibroblast (Fibro - A) and human Ntera2 cells (NT2 - B and C) measured relative to input. Each dataset included two independent technical replicates. The
presence of consistent signal peaks in each replicate within a dataset is noted by an asterisk (*), as indicated. D corresponds to C but measured relative to an
RNase H-treated control. Subtelomeric regions are arranged in the same order as a. See ‘Results’ for details. (c) Representative screenshots of DRIP-seq data
over three distinct subtelomeric regions (22q, 15q and 10q, as indicated). Normalized DRIP-seq signal densities are displayed for each region over two distinct
replicates (indicated by (I) and (II)) as well as input and, when available, RNase H-treated controls. The position of the Pol2 promoters and putative TSSs is
shown at the top. Vertical dashed lines indicate the position of restriction enzyme sites used to fragment the genomic DNA before DRIP-seq. The grey shaded
area highlights a TRF encompassing the TERRA promoter and/or downstream regions showing significant DRIP-seq signal.
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seq data sets22,41,42. One data set (referred to as Fibro in Fig. 1c)
was generated from human primary fibroblasts42. Two
independent data sets (referred to as NT2 exp1 and NT2 exp2
in Fig. 1c) were generated from the human embryonal carcinoma
cell line Ntera2 (refs 22,41). Each dataset had two highly
correlated technical replicates (Supplementary Fig. 2). Having
established unequivocally that GC skew is a key determinant of
DNA:RNA hybrid formation in both cell types (Supplementary
Fig. 3), we proceeded to analyse these data sets for subtelomeric
hybrid formation. As shown in Fig. 1b, many subtelomeres
showed significant DRIP-seq signal enrichment over input in
most data sets. In one instance, DRIP-seq signal enrichment in
Ntera2 cells could be measured against an RNase H-treated
control (referred to as NT2 exp1 and NT2 exp1þRNase H in
Fig. 1b). Again, most subtelomeric regions, in particular those
predicted to be DNA:RNA hybrid-prone (Fig. 1a), showed
significant enrichment for DRIP-seq signal, strongly suggesting
the formation of DNA:RNA hybrids. Because the resolution of
DRIP-seq is limited by the occurrence of restriction enzymes used
to fragment the genome, we further explored the detailed patterns
of DNA:RNA hybrid formation for evidence that the signal
originates downstream of the TERRA promoter and TSS. In a
number of instances, the restriction enzymes had cleavage sites in
the immediate vicinity of the TERRA promoter, separating the
TERRA promoter and downstream regions from upstream
sequences (Fig. 1c). Strong DRIP-seq signals originating at or
near the TERRA promoter and encompassing downstream
subtelomeric regions adjacent to the telomere tract were
observed for a number of subtelomeres (Fig. 1c). Thus the
DRIP-seq data indicate that DNA:RNA hybrids can be generated
at many chromosome ends. This phenomenon is not restricted to
human cancer cells and occurs also in normal primary human
cells.
Telomeric DNA:RNA hybrids are elevated in ICF cells. Primary
human fibroblasts were shown previously to express low levels of
TERRA33; however, these levels appear to be sufficient for hybrid
formation at subtelomeric regions, as demonstrated above. As
hybrid formation is correlated with transcript levels26,43, we next
asked whether the levels of DNA:RNA subtelomeric/telomeric
hybrids would be influenced by TERRA levels. Cells from ICF
type I syndrome patients provide an excellent platform to answer
this question owing to their abnormally elevated TERRA levels.
ICF cells were shown previously to display elevated levels of
TERRA33,34,37 and here we validate this finding for individual
chromosome ends (Supplementary Fig. 4). We compared TERRA
levels of five LCLs generated from ICF syndrome patients with
four LCLs from normal individuals and three heterozygous
carriers of ICF type I syndrome. We did not detect statistically
significant differences between the normal and carrier LCLs
throughout the various analyses; therefore, these samples were
pooled together for further analyses and designated as the wild-
type (WT) control group. Quantitative reverse transcription–PCR
(qRT-PCR) analysis demonstrated that, while TERRA levels
varied among the different subtelomeres, they were consistently
higher in ICF compared with WT LCLs.
We then proceeded to determine the levels of DNA:RNA
hybrid formation in ICF versus WT cells by DRIP analysis.
Digested DNA from ICF and WT LCLs (Fig. 2a) was subjected to
DRIP using the S9.6 hybrid-specific antibody, and the amount of
immunoprecipitated material was compared with input using
qPCR for 11 subtelomeric regions and 3 control non-telomeric
regions (Fig. 2b,c and Supplementary Fig. 5a). No statistically
significant differences were observed in the enrichment of hybrids
at control regions between the WT and ICF groups, in agreement
with similar transcript levels of these genes (Supplementary
Fig. 5b). Treatment of the DNA samples prior to DRIP with
bacterial RNase H tested the specificity of the DRIP procedure,
and, as expected, RNase H treatment significantly reduced or
eliminated DRIP-qPCR signals emanating from both control and
subtelomeric regions (Supplementary Fig. 5c,d). This analysis
reveals that subtelomeric DNA:RNA hybrids form also in LCLs
and that hybrid levels vary among subtelomeres both in the WT
and the ICF groups (Fig. 2b,c). One-way analysis of variance for
repeated measurements revealed a significant difference (P value
o0.05) in the DRIP enrichment between the subtelomeres, for
both the WT and ICF groups. Importantly, the amount of
DNA:RNA hybrids at many of the tested subtelomeres was higher
for ICF cells than for WT cells (Fig. 2b,c), suggesting that high
TERRA expression leads to elevated formation of DNA:RNA
hybrids at chromosome ends. DRIP enrichment levels of each
individual LCL segregated the ICF from the WT group and six of
the tested subtelomeric regions showed a statistically significant
difference in hybrid formation between both groups (Fig. 2d).
Five of the subtelomeric regions tested here did not show
significant differences in DNA:RNA hybrid loads between WT
and LCLs, even though lower average hybrid levels in WT cells
were apparent for 10 of the 11 examined subtelomeres. Notably,
the three subtelomeres that most substantially differed in TERRA
levels between ICF and WT LCLs (2p, 10q and 15q) were also
those that displayed significantly higher hybrid formation in ICF
versus WT (Fig. 2d and Supplementary Fig. 4). Interestingly,
the cumulative GC skew calculated downstream of the TERRA
TSS/promoter segregated subtelomeres whose hybrid formation
was affected by high TERRA levels in ICF cells from those that
were not affected (Fig. 2e). Collectively, these data suggest that
the formation of DNA:RNA hybrids at chromosome ends is
influenced by the sequence characteristics of the region adjacent
to the telomeric tract, including the TERRA promoter and TSS,
and is promoted by elevated levels of TERRA and/or by
perturbation of the normal chromatin structure in these regions
in ICF syndrome cells.
(TTAGGG)n are crucial for forming chromosome end hybrids.
As demonstrated above, the ability of human telomeric repeats to
form DNA:RNA hybrids was confirmed in vitro by us
(Supplementary Fig. 1) and another study30. Direct study of
telomere repeat hybrids in vivo is impeded by the repetitive
nature of the regions, which prevents their amplification by PCR.
Therefore, DRIP analysis of terminal restriction fragments
(TRFs), utilizing subtelomeric primers, does not distinguish
whether hybrids are formed at telomere-repeats or subtelomeric
regions or both (Fig. 2a). In order to allow this distinction, we
searched for a common restriction site that would separate the
telomeric tract from the subtelomeric region downstream to the
TERRA promoter in several chromosome ends. We detected five
chromosome ends (7q, 8p, 9p, 13q and 21q) in which HinfI
restriction sites are properly positioned (Fig. 3a) and performed
DRIP on these subtelomeres. In this set of experiments, we first
digested all samples with the standard enzyme cocktail and then
set aside one half of each sample for further digestion with HinfI.
We then validated that the samples were digested efficiently, as
shown in Supplementary Fig. 6 (boxed section of the figure). We
analysed the paired samples (þ /H) by DRIP-qPCR for four
ICF LCLs (Fig. 3b,c) and four WT LCLs (Fig. 3d,e), including
subtelomeres that encompass a HinfI site (þHinfI) (Fig. 3b,d)
and subtelomeres lacking a distal HinfI site between the
hexameric repeat and the PCR-amplified region (HinfI)
(Fig. 3c,e and Supplementary Fig. 7). The DRIP enrichment
values obtained in the absence of HinfI digestion (H) were
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arbitrarily set at 1, and the enrichment values obtained following
HinfI digestion (þH) represent relative enrichment in
comparison to the H samples (Fig. 3b–e) (absolute
percentage of input data are shown in Supplementary Fig. 6
and Supplementary Table 1).
In the ICF samples, at all of the subtelomeres containing a
HinfI site close to the telomere tract, with the exception of 7q, a
significant reduction in hybrid enrichment (P valueo0.001) was
observed following removal of the telomeric sequence by HinfI
digestion (Fig. 3b). This reduction was not observed at
subtelomeres lacking a HinfI restriction site between the telomere
repeat and the region analysed by amplification (Fig. 3c and
Supplementary Figs 6 and 7), indicating that the additional HinfI
digestion per se did not affect DRIP efficiency. In the case of
subtelomere 22q, the enzyme cocktail generates a relatively long
TRF, and the additional digestion with HinfI, whose site is
present in close proximity upstream to the amplified region,
results in the release of a shorter TRF (Supplementary Fig. 7).
Analysis of subtelomere 22q revealed that, following HinfI
digestion, the hybrid enrichment levels were higher, indicating
that the upstream regions, now disconnected from the shorter
TRF, are not responsible for the generation of the DNA:RNA
hybrids in these regions. In WT samples, we noticed an average
decrease in hybrid enrichment after HinfI digestion in the same
subtelomeres that were affected in ICF; however, in contrast to
ICF samples, this decrease was not statistically significant
(Fig. 3d). The subtelomeres lacking a distal HinfI site failed to
demonstrate consistent differences in hybrid enrichment between
the HinfI-digested and non-digested samples (Fig. 3e). Altogether,
these results indicate that, while the hybrids are predicted
to initiate at subtelomeres in the vicinity of TSSs, they extend
into telomere-hexameric repeats, which constitute a crucial
component of the hybrids at chromosome ends.
High TERRA levels are present in ICF cells during S phase.
A mechanism by which TERRA could form DNA:RNA hybrids
concomitantly with telomere replication, leading to fork stalling
and telomere loss events, has been suggested previously for high
TERRA-expressing yeast cells, as well as for ICF cells14,44. Such a
mechanism would require TERRA to be present at high levels
during S phase. Measurement of TERRA levels at various cell-
cycle stages in the telomerase-positive HeLa, HT1080 and SJSA1
cell lines45–48 demonstrated a decline in TERRA levels in late S
and G2. On the other hand, in ALT-positive cells, in which
TERRA levels are much higher, no decline from S to G2 phases
was found46. As shown previously33,34 and here (Supplementary
Fig. 4), TERRA levels are markedly elevated in cycling ICF cell
populations; however, TERRA levels at specific cell-cycle stages in
ICF cells had not been determined previously. To this end,
avoiding drug-induced cell-cycle synchronization, we used live
cell DNA staining (Vybrant DyeCycle Violet stain) and sorted
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Figure 2 | Telomeric DNA:RNA hybrids form preferentially in ICF cells. (a) Schematic representation of the subtelomeric regions subjected to DRIP-qPCR
analysis. Subtelomeric sequence appears as a straight line and telomeric TTAGGG repeats as a zigzagged line. The approximate 1,000bp upstream
to the telomere tract contains the TERRA promoter and TSS, and the two horizontal head-to-head arrows depict the location of the PCR primers used to
amplify the DRIP sample. Predicted TERRA promoters are present in the majority of analysed subtelomeres within the TRF. (b,c) DNA extracted from five
ICF and six WT LCLs was subjected to DRIP, followed by qPCR analysis of 11 subtelomeric amplicons representing 16 subtelomeric regions (Supplementary
Table 4). The amount of immunoprecipitated material is shown as a percentage of input for each subtelomere for WT (b) and ICF samples (c). Bars and
error bars represent means and s.e.m. calculated for all samples in each group over two to five independent experiments. (d) DRIP-qPCR values for each
subtelomere are displayed for each LCL (WT samples—blue triangles, ICF samples—red triangles). Two-tailed Student’s t-tests were performed to
determine statistical differences between WT and ICF samples (**¼ P value o0.01, *¼ P value o0.05). Six out of the 11 subtelomeres studied showed
significant differences. (e) GC skew downstream of TERRA promoter is predictive of increased DNA:RNA hybrid formation in ICF compared with WT LCLs.
GC skew information is as shown in Fig. 1a. The telomeres that appear in this figure are those that contain a putative TSS.
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three ICF and two WT LCLs into G1, S and G2 phases and
examined fraction purity based on propidium iodide staining
(Fig. 4, upper left corner). Following cell sorting, RNA was
extracted from each cell-cycle fraction, and cDNA was generated
using a telomere-specific oligonucleotide primer. TERRA cDNA
was subjected to qRT-PCR, examining five different subtelomeres
(Fig. 4). As expected, TERRA levels were higher in ICF cells for
four out of the five examined subtelomeres, (with the exception of
16p), in comparison to WT (P valueo0.001, Wilcoxon rank-sum
test). Notably, we found that TERRA levels were consistently
higher in S phase versus G1 phase for all the five studied
subtelomeres in all three tested ICF cells (P value
o0.001,Wilcoxon signed-rank test) while TERRA levels in the
two WT cell lines demonstrated relatively consistent levels of
TERRA throughout the cell cycle. The lowest difference in
TERRA levels between the ICF and WT groups was detected for
subtelomere 16p (Fig. 4), in agreement with the insignificant
increase of hybrid formation in ICF versus WT for this
subtelomere (Fig. 2d). In order to confirm that ICF LCLs
indeed vary in their TERRA distribution in comparison to
WT-LCLs, we analysed three additional WT-LCLs for TERRA
levels during the cell cycle. These additional WT controls
similarly demonstrated relatively consistent levels of TERRA
throughout the cell cycle (Supplementary Fig. 8). These findings
indicate that surprisingly, in contrast to previous studies on other
cell types, TERRA levels do not decline during S and G2 phases in
WT LCLs. Altogether these findings demonstrate that ICF LCLs
contain high levels of TERRA throughout the cell cycle, with even
higher levels present in S phase supporting the scenario that
telomeric DNA:RNA hybrids are present during this cell-cycle
phase in ICF cells.
Telomeric DNA:RNA hybrids form throughout the cell cycle.
We next examined whether high TERRA levels during S phase in
ICF cells correspond to the presence of telomeric DNA:RNA
hybrids during this cell-cycle stage. To our knowledge, cell-cycle
analysis of DNA:RNA hybrids was not investigated previously.
We therefore sorted three ICF and two WT LCLs, as described
above, to obtain cells from G1, S and G2 phases and proceeded
with DRIP on these cell-cycle fractions probing six subtelomeric
regions (Fig. 5, and Supplementary Fig. 9). Enrichment values
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Figure 3 | Telomere-hexameric repeats are a major component of DNA:RNA hybrids at chromosome ends. (a) A schematic representation of the
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line. The two horizontal head-to-head arrows depict the location of the PCR primers used to amplify the DRIP sample. In a subset of subtelomeres, a HinfI
restriction site is present in close proximity to the telomere tract (right vertical arrow), downstream to the region amplified by PCR. When DNA is digested
with HinfI in addition to the enzyme cocktail, a subtelomeric region disconnected from the telomere tract may be pulled down by DRIP. The PCR primers
depicted in the scheme will amplify such fragments. (b–e) DNA samples of four ICF LCLs (pCor, pG, pY, pH) and four WT LCLs (GM08729, GM19116c, fY,
3125) were digested with the enzyme cocktail and then each sample was split into two fractions. One of these fractions was further digested with HinfI, and
DRIP was performed on both fractions. The enrichment values with (þH) and without (H) HinfI digestion were compared, setting the enrichment value
of samples lacking the additional HinfI digestion as 1. Each line connects between the enrichment values of the same sample with or without additional HinfI
digestion. (b,d) Analysis of subtelomeres that contain a HinfI restriction site in close proximity to the telomere as described in panel a. (c,e) Analyses of
subtelomeres that lack a HinfI restriction site and serve as controls. (b,c) Analyses of various subtelomeres, with and without HinfI sites, in four ICF
samples. (d,e) Analysis of various subtelomeres, with and without HinfI sites, in four WT samples. ***¼ P values o0.001, two-tailed Student’s t-test.
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obtained from G1 fractions were set at 1, and enrichment values
obtained from the S and G2 fractions were compared relative to
the G1 values. In agreement with the relatively high TERRA levels
detected at all cell-cycle stages in ICF LCLs (Fig. 4), DNA:RNA
hybrids were detected throughout the cell cycle. The enrichment
in S phase was significantly higher in comparison to G1 (P value
o0.05, Wilcoxon signed-rank test) for the analysed subtelomeres
in samples ICF1 and ICF2, however, not so for ICF3. In WT cells,
no consistent pattern of cell-cycle stage-specific enrichment was
apparent. Altogether, these finding demonstrate that telomeric
DNA:RNA hybrids are present both in ICF and WT cells
throughout the cell cycle with no distinct and reproducible
pattern in all the examined cell lines and suggest that, when
present in S-phase, these DNA:RNA hybrids could affect telomere
replication.
Telomeres in ICF cells display RNase H1-sensitive DNA damage.
Several observations suggest that DNA double-strand breaks arise
from a collision between the replication machinery and an R-loop
(reviewed in refs 49 and 50). Double-strand breaks resulting from
such encounters at telomeric regions could lead to telomere loss.
To further explore this possibility in ICF cells, we tested whether
ICF cells display DNA damage at telomeric regions. LCLs grow in
suspension and are not readily amenable for 3D-interphase
analysis of telomere-dysfunction-induced foci. We therefore
proceeded to examine the occurrence of DNA damage signals
(DDSs) at chromosome ends in mitotic cells in ICF and WT
LCLs. To enrich for cells in metaphase, the LCLs were briefly
treated with colcemid, then cytospun on slides and subjected to
immunofluorescence with an antibody against g-H2AX, a marker
for DNA damage. DDSs were detectable both along the
chromosome arms and at the extreme chromosome ends, with
signals emanating from either one or from both sister chromatids
(Fig. 6a,b). Scoring the percentage of g-H2AX-positive chromo-
some ends (either from one or two chromatids) in three ICF LCLs
and three WT LCLs indicated that ICF LCLs exhibited sig-
nificantly higher DNA damage signals at these loci (Fig. 6c and
Supplementary Table 2). In contrast, no significant difference in
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the percentage of the DDS positioned along the chromosome
arms was evident between the ICF and WT groups
(Supplementary Fig. 10).
We next explored whether the chromosome-end DDSs are
related to the observed higher levels of DNA:RNA hybrids at
telomeric regions in ICF cells. To address this question, we
ectopically expressed RNase H1 in two ICF and two WT LCLs.
Lentiviral constructs containing RNase H1-GFP (green fluores-
cent protein) and a control cytoplasmic-GFP were used to infect
the LCLs, and GFP-positive cells were separated by a fluores-
cence-activated cell sorter (FACS) and propagated in culture. We
analysed the levels of RNase H1 by qRT-PCR in the sorted cells
and found a eightfold increase in those expressing RNase H1-GFP
in comparison to the control-GFP cells. In addition, we verified
that hybrids at a non-telomeric and telomeric regions were
reduced in the RNase H1-treated cells in comparison to the
control-only GFP-expressing cells (Supplementary Fig. 11).
Approximately a week after the infection, the cells were subjected
to immunofluorescence on metaphase chromosomes to detect
g-H2AX, as described above. In WT LCLs, which display lower
basal levels of chromosome-end DDS, the expression of RNase
H1 led to increased levels of chromosome-end DDS in one
WT LCL, whereas the other displayed a slight reduction.
However, strikingly, in both ICF LCLs, overexpression of RNase
H1 resulted in a significant reduction in g-H2AX-positive
chromosome ends (Fig. 6d and Supplementary Table 3), down
to the levels observed in WT cells. These findings support
the notion that, in ICF cells, DNA:RNA hybrids lead to DNA
damage at telomeric regions, which, if not repaired, may lead to
telomere loss.
Discussion
DNA:RNA hybrids at telomeric regions have been demonstrated
previously in yeast and in human telomerase-positive and ALT
cancer cells14,28,30. The data presented here demonstrate for the
first time that DNA:RNA hybrids form at chromosome ends also
in primary WT fibroblasts and in LCL lines derived from normal
individuals. Using the whole-genome DRIP-seq approach, these
hybrids are detected in the majority, but not in all, of
chromosome ends in human fibroblasts and in the NT2 human
embryonal carcinoma cell line (Fig. 1b,c). Our analysis focussed
on the last 2 kb of subtelomeric regions, where TERRA promoters
and TSSs have either been described7 or are predicted to reside40.
The presence of such hybrids in normal cells, albeit in low levels,
suggests that the low TERRA levels present in normal cells are
sufficient to elicit hybrid formation.
Although the human telomeric (TTAGGG)n repeat was shown
by in vitro studies to form hybrids (ref. 30 and Supplementary
Fig. 1), no direct in vivo evidence for the involvement of these
sequences in hybrid generation was available. The protocol
utilized in the previous study30, as well as in our study, cannot
discriminate whether the subtelomeric regions detected following
the DRIP procedure were pulled down by the S9.6 antibody based
on hybrids present in telomeric regions or in subtelomeric
regions, or both. Here we demonstrate clearly that the enrichment
for hybrids is significantly reduced when subtelomeric regions are
subjected to DRIP following the removal of the adjacent telomeric
repeats (Fig. 3). Hence, the perfectly GC-skewed telomeric repeat,
which comprises the majority of the TERRA molecules,
contributes greatly to the hybrids formed at chromosome ends.
The stability of hybrids forming at such regions could be further
enhanced by the propensity of the displaced G-rich telomeric
DNA to form G-quadruplexes51.
All mammalian chromosomes end with the canonical
TTAGGG repeat, and human subtelomeres share many common
characteristics, such as a high GC content, enrichment for the
dinucleotide CpG, telomere-like repeats and families of larger
repeats7,8. Despite these similarities, subtelomeric sequences vary
noticeably10. Based on several sequence characteristics of the
distal chromosome ends, we predicted that the capability to
generate DNA:RNA hybrids would differ among various
subtelomeres. In particular, this expectation was supported by
the occurrence of GC-skewed regions, which were shown to be
highly prone to hybrid formation22, and which are present in
close vicinity to the putative TERRA promoters (Fig. 1). Indeed,
our findings from both whole-genome DRIP-seq data and from
probing individual subtelomeres suggest that subtelomeres differ
in their capacity to form hybrids (Figs 1b,c and 2). If indeed this is
the case, the subtelomeric regions that comprise the 50-end of the
TERRA molecules may be the regions that ‘seed’ the formation of
hybrids, which then could extend further into the telomere-repeat
region. The difference between human telomeres in their capacity
to instigate formation of DNA:RNA hybrids suggests that the
integrity of specific chromosome ends may be more at risk than
others. Further studies will determine whether and how a specific
subtelomeric sequence can influence the function of the telomere
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Figure 5 | Telomeric DNA:RNA hybrids form during all stages of the cell
cycle in ICF LCLs. Three ICF LCLs (pCor, pG and pY, designated as ICF1,
2 and 3, respectively) and two WT LCLs (GM08729 and GM19116c
designated WT1 and 2, respectively) were sorted to G1, S and G2 phases,
after which DRIP was performed and probed for the relative enrichment of
six subtelomeric regions at the various cell-cycle phases. For each
subtelomere, the enrichment in G1 was set at one, and the enrichment in
S and G2 was compared relatively with the G1 values. Bars and error bars
represent means and s.e.m. of two experimental repeats.
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in cis and whether in physiological aging or in other situations
where TERRA is dysregulated, such as in ICF syndrome, human
telomeres differ in their propensity to shorten.
ICF type I cells are severely hypomethylated at subtelomeric
regions, display a short telomere phenotype and express TERRA
at extremely high levels33. Previous studies have demonstrated
that TERRA is upregulated at short telomeres15 and the scenario
that the short telomere length in ICF syndrome influences
TERRA levels cannot be ruled out. However, the high TERRA
levels are an inherent characteristic of these cells independent of
telomere length, as high TERRA persists in ICF cells also when
telomeres are substantially elongated either by ectopic expression
of hTERT or by reprogramming to iPSCs33,37. As TERRA is
the main candidate RNA for forming DNA:RNA hybrids at
subtelomere/telomeric regions, we studied whether such hybrids
will form preferentially in ICF cells. However, the involvement of
additional telomeric transcript species52 in telomeric hybrids
cannot be excluded. Indeed, formation of DNA:RNA hybrids at
human telomeric regions is enhanced in ICF LCLs, and clearly,
the group of subtelomeres that differs most substantially in their
TERRA levels between ICF and WT LCLs are those that also
display significantly elevated hybrid formation in ICF cells. We
cannot preclude, however, that additional characteristics of the
subtelomeric and telomeric region such as the hypomethylation
or aberrant chromatin modifications34 contribute to hybrid
formation. Accelerated telomere shortening in ICF syndrome
could be a direct consequence of the subtelomeric/telomeric
DNA:RNA hybrids, as unscheduled collisions between replication
and transcription machinery have been shown to evoke double-
strand breaks via DNA:RNA hybrid formation49,53. We postulate
that, in the scenario of abnormally elevated TERRA levels,
particularly during the phase at which telomeres are replicated,
RNase H and additional factors that normally handle the levels of
DNA:RNA hybrids would fail to deal with the hybrid overload.
This would result in the accumulation of telomeric hybrids,
interference with the telomere replication process and generation
of DNA damage. To this end, we demonstrate that ICF
LCLs display significantly higher levels of TERRA at several
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Figure 6 | Chromosome end DNA damage signals in ICF LCLs are RNase H1 sensitive. (a–c) Cytospun metaphase spreads of three ICF LCLs pCor, pG and
pY (designated ICF 1, 2 and 3, respectively) and three WT LCLs GM08729, GM19116c and 3125 (designated WT 1, 2 and 3, respectively) were stained with
an antibody for g-H2AX and were then scored for the percentage of chromosome ends displaying g-H2AX signals (either at one or both sister chromatids)
(a,b). Representative stained metaphases of ICF1 (a) and ICF3 (b). Red arrows point to a single chromatid-stained chromosome end, white arrows point to
a double-chromatid stained chromosome end and the yellow arrow points to a g-H2AX signal positioned along the chromosome arm. The chromosome
boxed by the dotted line is enlarged in the upper left corner. Bar equals 10 mM. (c) All three ICF samples display a significantly higher percentage of g-H2AX
signals at their chromosome ends in comparison to each of the WT samples (P value o0.001, Proportions test. All P values appear in Supplementary
Table 2). At least 400 chromosomes were scored for each sample. Bars and error bars represent percentages and s.e.m. (d) RNase H1-GFP or cytoplasmic
GFP were expressed in ICF1, ICF3, WT1 and WT2 LCLs, sorted based on GFP expression and analysed for chromosome end g-H2AX signals. A minimum of
180 chromosomes was scored for each sample. ‘RNaseH’ refers to cells expressing the fused RNase H1-GFP. ‘Control’ refers to cells expressing the
cytoplasmic-GFP. The levels of g-H2AX signals at chromosome ends were significantly decreased in the ICF samples expressing RNase H1-GFP (P value
o0.05 Proportions test. All P values appear in Supplementary Table 3). Bars and error bars represent percentages and s.e.m.
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chromosome ends throughout the cell cycle, especially during S
phase, in comparison to WT LCLs (Fig. 4). Correspondingly,
telomeric hybrids are detected in ICF cells during all the cell-cycle
phases (Fig. 5). In two of the ICF LCLs that consistently showed
higher levels of TERRA (ICF1 and ICF2), the enrichment of
hybrids is even higher in S phase relative to G1. Excessive
telomeric hybrids are expected to trigger DNA damage, and in
agreement with this prediction, we demonstrate that indeed DNA
damage occurs at higher levels at chromosome ends in ICF LCLs
(Fig. 6a–c and Supplementary Table 2). To further support the
involvement of hybrids in the chromosome end DNA damage, we
ectopically expressed RNase H1 in ICF and WT cells. Strikingly,
this leads to a reduction in telomeric hybrids concomitantly with
significantly decreased chromosome-end DNA signals (Fig. 6d
and Supplementary Table 3). Although this is most likely due to
telomeric DNA:RNA hybrid degradation, we cannot exclude that
RNase H1 also suppresses telomeric damage through a yet
unexplored function. Altogether, our findings strongly support
the hypothesis that, in ICF syndrome, TERRA is the culprit that
evokes damage at telomeres by engaging in DNA:RNA hybrid
formation49,53,54. Further studies will elucidate whether
additional telomeric transcripts evoke hybrids, as well as when
precisely during the cell cycle telomeric hybrids are formed.
Nevertheless, ICF syndrome belongs to the emerging group of
human diseases55 in which dysregulation of a long non-coding
RNA is strongly associated with an abnormal phenotype.
Cancer cells that employ the ALT pathway to maintain
telomeres are also hypomethylated at subtelomeric regions and
transcribe high levels of cell-cycle-dysregulated TERRA46,56–59. In
ALT cells, the high TERRA levels are suggested to contribute to
the elevated levels of hybrids, and accumulation of telomeric
hybrids could lead to the homologous recombination typical to
these cells30. ICF telomeres, contrary to ALT cancer cells, do not
engage in recombination33. These different outcomes of
high TERRA and telomeric hybrids may relate to the fact that
ICF cells are untransformed and normally suppress telomere
recombination, in contrast to ALT cells that carry mutations that
unleash telomere recombination46,54,60.
Regardless of the outcome, abnormally high levels of TERRA
and the resulting enrichment of hybrids at telomeric regions are
likely to endanger the integrity of human telomeres. Future
studies that manipulate TERRA levels in various cell types,
including ICF cells, will further establish the causative role of
TERRA and the mechanisms by which telomeric DNA:RNA
hybrids impede the normal maintenance of human telomeres.
Methods
Cell lines and cell culture. ICF LCLs pCor, pG, pH, pT and pY61 (designated as
ICF1, 2, 4, 5 and 3, respectively) were grown in RPMI supplemented with 20% FCS,
2mM glutamine, 100Uml 1 penicillin and 100mgml 1 streptomycin. Control
WT LCLs included the following: 3125 and 3133 (ref. 62), GM08729, GM08728
(ref. 33) and GM119116c (designated as WT 3, 7, 1, 6 and 2, respectively), obtained
from Coriell Cell Repositories, and fY and mY LCLs generated from blood samples
obtained with consent from the parents of patient pY (designated as WT 4 and 5
respectively). All control WT LCLs were grown in similar media as above,
supplemented with 15% FCS. The S9.6-producing hybridoma cell line (HB-8730)
was purchased from ATCC (Manassas, VA, USA) and grown in DMEM
supplemented with 10% FCS, 2mM L-Glutamine Solution and 100mM Sodium
Pyruvate.
Plasmids. The telomere-repeat containing plasmids were prepared as following:
A 240 bp PstI fragment containing 40 telomere repeats was released from the
pHuR93 (ATCC 61076) plasmid63 and cloned into the pBlueScript vector,
generating pBS-240bpTEL. An 810 bp HindIII-KpnI fragment containing 135
telomere repeats was released from pSXneo 270(T2AG3) (Addgene plasmid no.
12403, a gift from Titia de Lange64) and cloned into the pFC53 plasmid generating
pFC53-800bpTel. A pFC53 plasmid containing mAIRN served as a positive control
for DNA:RNA hybrids (pFC53-mAIRN22).
An RNase H1-expressing plasmid was prepared by amplification of a fragment
containing the human RNase H1 starting at M27, fused to enhanced GFP (eGFP),
from the pEGFP-M27-H1 plasmid (a gift from Robert Crouch)65. The primers
used for amplification were: Forward—50-CTCAGATCTCGAGCTCAAGC-30,
containing a BglII restriction site (underlined) and Reverse—50-AGTCGACTTT
ACTTGTACAGCTCG-30 , containing a SalI restriction site (underlined).
The approximately 1.58 kb amplified fragment was TA-cloned into pCR2.1
(Invitrogen). Sanger sequencing confirmed the sequence of a pCR2.1-RNase
HI-eGFP-positive clone. The pTK-H1-eGFP plasmid was generated by subcloning
the BglII-SalI fragment from the pCR2.1-RNase HI-eGFP plasmid into the BamHI
and XhoI sites of the lentiviral vector pTK208, containing the cytomegalovirus
promoter. Plasmid pTK113 contains the eGFP gene cloned into the pTK208
plasmid. Both pTK208 and pTK133 are gifts from Tal Kafri.
Calculation of CpG density and GC content and GC skew. CpG density,
GC content and GC skew of 2 kb subtelomeric regions adjacent to the telomere
tract were calculated using standard equations with sliding window method23.
Heatmaps and clusters were created using heatmap.3 function from R package
‘GMD’. Analysis of these regions was carried out on the GenoMatix software suite
utilizing the PromoterInspector program for identification of putative Pol II
promoter regions40. TSSs were predicted based on Nergadze et al.7
DRIP analyses. The S9.6 antibody was produced from the HB-8730 cell line either
by recovery from ascites fluid and purification to homogeneity by Antibodies Inc.
(Davis, CA, USA)22 or as following: the HB-8730 cells were transferred to growth
in serum-deprived medium (0.5% FCS in RPMI) for 48 h. Ammonium sulfate was
added to the medium supernatant to 29.1 g per 100ml, and the samples were
stirred for 30min at 4 C. The ammonium sulfate precipitate was pelleted at
34,155g for 20min, resuspended in a few millilitres of 10% glycerol/1 PBS and
subjected to overnight dialysis in the same buffer. The concentration and efficiency
of the antibody prepared in this way were validated by comparison to the
commercial S9.6 antibody (ENH001, KeraFAST).
DRIP was carried out based on ref. 22 and detailed here: Five million cells were
washed in PBS, centrifuged, and resuspended without pipetting in 1.6ml TE with
83 ml of 10% SDS and 5 ml of 20mg per ml proteinase K and incubated overnight
at 37 C. The next morning, DNA was extracted with phenol/chloroform/
isoamylalcohol (25:24:1) (Affymetrix, no. 75831) using phase lock tubes (5prime,
no. 2302840). After partial resuspension in TE, DNA was fragmented with XhoI,
SspI, HindIII, EcoRI and BsrGI in 2.1 digestion buffer (NEB) containing 2mM
spermidine. Twenty five units of RNase H (NEB, no. M0297) were added to half of
each sample to serve as a negative control, and the samples were incubated
overnight at 37 C. Following extraction in phenol/chloroform/isoamylalcohol
(25:24:1) in 2ml phase lock tubes, DNA concentration was determined using a
NanoDrop ND-1000, and an aliquot was separated by agarose gel electrophoresis to
validate efficient digestion. After setting aside 1% for input control, 4 mg of DNA
were used for immunoprecipitation overnight with binding buffer (10mM NaPO4,
pH 7.0/0.14M NaCl/0.05% Triton X-100) and 10 mg of the S9.6 antibody on a
rotisserie shaker at 4 C. The following morning, 50 ml of agarose A/G beads (Pierce
no. 20421) were prewashed 2 3 times with binding buffer and added to the
DNA/antibody complex and incubated for 2 h at 4 C on a rotisserie shaker.
After three washes with binding buffer at room temperature for 10min each,
the beads were eluted with 250ml elution buffer (50mM Tris pH 8.0, 10mM
EDTA, 0.5% SDS) and 7 ml proteinase K (20mg per ml) for 45min on a rotisserie
shaker at 55 C. Finally, the eluted DNA was extracted with phenol/chloroform/
isoamylalcohol (25:24:1), precipitated with ethanol and resuspended in 50 ml of TE
for analysis by qPCR.
When DRIP experiments were performed with an additional HinfI digestion,
DNA was first digested overnight with the standard enzyme cocktail and then split
into two equal aliquots. HinfI was added to one of the aliquots, and both aliquots
were incubated at 37 C for 3 h and then processed as described above. Primers
used for qPCR reactions were designed using the Primer Express Software
(Thermo Fisher Scientific) in regions as close as possible to the telomere tract,
based on the reported subtelomeric sequences10. Owing to the repetitive nature of
the subtelomeric regions, some of the primer pairs amplify more than one
chromosome end. Primer sequences, their relative position to the most distal
HinfI site and their genomic locations are described in Supplementary Table 4.
All designed primers were calibrated to ensure optimal conditions for
amplification. The percentage of input was calculated as 2(Ct1%inputCtoutput).
DRIP-seq Mapping. Input, untreated and bacterial RNase H-treated DRIP-seq
data sets from WT human primary fibroblasts42 and the human testicular
carcinoma cell line, Ntera2 (ref. 41), were quality/adapter-trimmed using
fastq-mcf66 and mapped using Bowtie2 v2.1.0 (ref. 67) to human genome
version GRCh37/hg19 supplemented by DNA sequences representing missing
subtelomeric regions, when necessary. PCR duplicates were removed using
SAMtools68. Peaks were called using MACS v2.1 (ref. 69) with input or RNase
H-treated samples as controls. Fold enrichments for the most distal 2 kb of
subtelomeric region of each chromosome were aggregated from peaks in that
region.
ARTICLE NATURE COMMUNICATIONS | DOI: 10.1038/ncomms14015
10 NATURE COMMUNICATIONS | 8:14015 | DOI: 10.1038/ncomms14015 | www.nature.com/naturecommunications
Cell sorting. Cell sorting by DNA content was carried out as following: One
microlitre of Vybrant DyeCycle Violet Stain (V35003, Life Technologies) was
added to 1ml of growth media, and the cells were stained at a concentration of
1 million cells per ml dye-containing-medium for 1–6 h at 37 C. Cells were then
sorted on a FACS Aria IIIu Cell Sorter using Violet 405 nm for excitation with a
450/40 nm bandpass filter. The irregular shape of the LCLs required the use of a
130 nm nozzle. The cells were sorted into three fractions corresponding to G1,
S and G2 phases, based on the DNA content histogram. Following the sorting,
100,000 cells from each fraction were fixed in EtOH, stained with Propidium Iodide
for 15min and analysed on a FACSCalibur to validate the purity of the sorted
fractions. A total of 3 105 and 8 105 cells per cell-cycle fraction were collected
for RNA and DRIP experiments, respectively. Sorting of GFP-positive LCLs was
carried out under aseptic conditions on the FACS Aria IIIu Cell Sorter using the
130 nm nozzle.
RNA extraction and qRT-PCR. ICF LCLs, whose growth is considerably atte-
nuated, required sorting of approximately 40 million cells in order to obtain a
sufficient number of cells from S and G2 phases for expression analysis. Sorted cells
intended for RNA extraction were collected into 5ml tubes containing 1ml
RNAlater solution (AM7020, Thermo Fisher Scientific). When the total volume in
the tubes reached 4.5ml, cells were centrifuged at 840g and resuspended in 1ml
RNAlater. RNA was extracted using the RNeasy Micro Kit (no. 74004, QIAGEN)
and an additional DNase treatment with TURBO DNase (AM2238, Thermo Fisher
Scientific) was carried out in order to eliminate any trace of DNA in the pre-
paration. RNA concentrations were determined by Qubit fluorometric quantita-
tion. Total RNA was reverse transcribed at 55 C with SuperScript III reverse
transcriptase (Invitrogen) using a b-actin-specific primer (50-AGTCCG
CCTAGAAGCATTTG-30) and a TERRA-specific primer composed from five
telomere-hexameric repeat ((CCCTAA)5)38. cDNAs were then analysed with the
same primers used for DRIP (Supplementary Table 4). qRT-PCR was carried out
on an Applied Biosystems StepOnePlus Real-Time PCR system with Fast SYBR
Green Master Mix (AB-4385612, Applied Biosystems). Analysis was carried out by
the delta delta Ct method using the b-actin gene as the reference45.
Lentiviral infections. Each LCL was infected serially twice with virions produced
from either pTK-H1-eGFP or from pTK113 plasmids in the HEK293FT packaging
cell line. Virus-containing supernatant was collected 48–72 h after transfection and
polybrene was added to a final concentration of 8 mg per ml. Ten millilitres of
virus-containing media were added to 5–10 106 cells in a 15ml tube, and the cells
were spun for 90min at 450g at 25 C. Following this, the cells were incubated at
normal growth conditions (37 C, 5% CO2) overnight. The following day, the cells
were either subjected to a second round of infection or were washed and placed in
virus-free growth media for 2–3 days, after which the GFP-positive cells were
collected by sorting.
Chromosome end cH2AX staining and microscopy. Following sorting, the GFP-
positive LCLs were expanded in culture for approximately a week. gH2AX staining
of metaphase spreads was based on ref. 70 and carried out as following: Prior to
staining, the cells were incubated with 20 ngml 1 colcemid for exactly 50min.
Cells were then centrifuged for 5min at 310g and the cell pellet was resuspended in
freshly prepared hypotonic solution (0.2% KCl, 0.2% Sodium Citrate in double
distilled water (DDW)) at a concentration of 5 104 cellsml 1. Cells were
incubated in the hypotonic solution at room temperature for 8min exactly and
cytocentrifuged for 10min at 2000 RPM with medium acceleration on a Cytospin 3
centrifuge (SHANDON). Following fixation for 10min in 4% paraformaldehyde in
1 PBS, slides were rinsed in water and permeabilized with KCM buffer (120mM
KCl, 20mM NaCl, 10mM Tris pH 7.5, 0.1% Triton) for 10min at room
temperature. The slides were blocked with 100 mgml 1 RNase A, 5% BSA in
1 PBS for 30min at 37 C. Slides were then incubated for 1 h at 37 C with a
mouse anti-phosphorylated gH2AX antibody (no. 05-636, Upstate) diluted 1:300 in
3% FCS, 0.1% triton in 1 PBS. Slides were then washed three times for 5min in
0.1% Triton in PBS (PBST) at room temperature and incubated with a secondary
antibody for 1 h at 37 C. After three washes in PBST, the slides were mounted with
VECTASHIELD antifade containing 4,6-diamidino-2-phenylindole (H-1200,
VECTOR LABORATORIES). Images were visualized on a BX50 microscope
(Olympus), and captured with an Olympus DP73 camera controlled by the cellSens
Entry Microscopy Imaging software (Olympus).
Statistical analysis. For each statistical analysis, we examined normality by
Shapiro–Wilk Normality test and examined homoscedasticity between groups by
Levene’s test. When the data did not meet the assumptions of the parametric tests,
we calculated the statistics by non-parametric tests as Wilcoxon signed-rank test
for paired samples or the Wilcoxon signed rank-sum test (Mann–Whitney U-test)
for non-paired samples.
Data availability. DRIP-seq data sets were published in Ginno et al.41 and Lim
et al.42 The data sets are available in the NCBI Gene Expression Omnibus (GEO;
http://www.ncbi.nlm.nih.gov/geo/) under accession number GSE45530 and
GSE57353, respectively.
References
1. Hug, N. & Lingner, J. Telomere length homeostasis. Chromosoma 115, 413–425
(2006).
2. Giraud-Panis, M. J. et al. One identity or more for telomeres? Front. Oncol. 3,
48 (2013).
3. Palm, W. & de Lange, T. How shelterin protects mammalian telomeres. Annu.
Rev. Genet. 42, 301–334 (2008).
4. Allsopp, R. C. & Harley, C. B. Evidence for a critical telomere length in
senescent human fibroblasts. Exp. Cell Res. 219, 130–136 (1995).
5. Hemann, M. T., Strong, M. A., Hao, L. Y. & Greider, C. W. The shortest
telomere, not average telomere length, is critical for cell viability and
chromosome stability. Cell 107, 67–77 (2001).
6. Zou, Y., Sfeir, A., Gryaznov, S. M., Shay, J. W. & Wright, W. E. Does a sentinel
or a subset of short telomeres determine replicative senescence? Mol. Biol. Cell
15, 3709–3718 (2004).
7. Nergadze, S. G. et al. CpG-island promoters drive transcription of human
telomeres. RNA 15, 2186–2194 (2009).
8. Ambrosini, A., Paul, S., Hu, S. & Riethman, H. Human subtelomeric duplicon
structure and organization. Genome Biol. 8, R151.151–R151.113 (2007).
9. Galati, A., Micheli, E. & Cacchione, S. Chromatin structure in telomere
dynamics. Front. Oncol. 3, 46 (2013).
10. Stong, N. et al. Subtelomeric CTCF and cohesin binding site organization using
improved subtelomere assemblies and a novel annotation pipeline. Genome Res.
24, 1039–1050 (2014).
11. Azzalin, C. M., Reichenback, P., Khoriauli, L., Giulotto, E. & Lingner, J.
Telomeric repeat containing RNA and RNA surveillance factors at mammalian
chromosome ends. Science 318, 798–801 (2007).
12. Schoeftner, S. & Blasco, M. A. Developmentally regulated transcription of
mammalian telomeres by DNA-dependent RNA polymerase II. Nat. Cell Biol.
10, 228–236 (2008).
13. Azzalin, C. M. & Lingner, J. Telomere functions grounding on TERRA firma.
Trends Cell Biol. 25, 29–36 (2014).
14. Balk, B. et al. Telomeric RNA-DNA hybrids affect telomere-length dynamics
and senescence. Nat. Struct. Mol. Biol. 20, 1199–12052 (2013).
15. Cusanelli, E., Romero, C. A. & Chartrand, P. Telomeric noncoding RNA
TERRA is induced by telomere shortening to nucleate telomerase molecules at
short telomeres. Mol. Cell 51, 780–791 (2013).
16. Maicher, A., Kastner, L. & Luke, B. Telomeres and disease: enter TERRA. RNA
Biol. 9, 843–849 (2012).
17. Pfeiffer, V. & Lingner, J. TERRA promotes telomere shortening through
exonuclease 1-mediated resection of chromosome ends. PLoS Genet. 8,
e1002747 (2012).
18. Redon, S., Zemp, I. & Lingner, J. A three-state model for the regulation of
telomerase by TERRA and hnRNPA1. Nucleic Acids Res. 41, 9117–9128 (2013).
19. Vitelli, V. et al.More on the lack of correlation between TERRA expression and
telomere length. Front. Oncol. 3, 245 (2013).
20. Rippe, K. & Luke, B. TERRA and the state of the telomere. Nat. Struct. Mol.
Biol. 22, 853–858 (2015).
21. Santos-Pereira, J. M. & Aguilera, A. R loops: new modulators of genome
dynamics and function. Nat. Rev. Genet. 16, 583–597 (2015).
22. Ginno, P. A., Lott, P. L., Christensen, H. C., Korf, I. & Chedin, F. R-loop
formation is a distinctive characteristic of unmethylated human CpG island
promoters. Mol. Cell 45, 814–825 (2012).
23. Hartono, S. R., Korf, I. F. & Chedin, F. GC skew is a conserved property of
unmethylated CpG island promoters across vertebrates. Nucleic Acids Res. 43,
9729–9741 (2015).
24. Lombrana, R., Almeida, R., Alvarez, A. & Gomez, M. R-loops and initiation of
DNA replication in human cells: a missing link? Front. Genet. 6, 158 (2015).
25. Yu, K., Chedin, F., Hsieh, C. L., Wilson, T. E. & Lieber, M. R. R-loops at
immunoglobulin class switch regions in the chromosomes of stimulated B cells.
Nat. Immunol. 4, 442–451 (2003).
26. Gan, W. et al. R-loop-mediated genomic instability is caused by impairment of
replication fork progression. Genes Dev. 25, 2041–2056 (2011).
27. Groh, M. & Gromak, N. Out of balance: R-loops in human disease. PLoS Genet.
10, e1004630 (2014).
28. Pfeiffer, V., Crittin, J., Grolimund, L. & Lingner, J. The THO complex
component Thp2 counteracts telomeric R-loops and telomere shortening.
EMBO J. 32, 2861–2871 (2013).
29. Yu, T. Y., Kao, Y. W. & Lin, J. J. Telomeric transcripts stimulate telomere
recombination to suppress senescence in cells lacking telomerase. Proc. Natl
Acad. Sci. USA 111, 3377–3382 (2014).
30. Arora, R. et al. RNaseH1 regulates TERRA-telomeric DNA hybrids and
telomere maintenance in ALT tumour cells. Nat. Commun. 5, 5220 (2014).
31. Xu, G. L. et al. Chromosome instability and immunodeficiency syndrome caused
by mutations in a DNA methyltransferase gene. Nature 402, 187–191 (1999).
NATURE COMMUNICATIONS | DOI: 10.1038/ncomms14015 ARTICLE
NATURE COMMUNICATIONS | 8:14015 | DOI: 10.1038/ncomms14015 | www.nature.com/naturecommunications 11
32. Okano, M., Bell, D. W., Haber, D. A. & Li, E. DNA methyltransferases Dnmt3a
and Dnmt3b are essential for de novo methylation and mammalian
development. Cell 99, 247–257 (1999).
33. Yehezkel, S., Segev, Y., Viegas-Pequignot, E., Skorecki, K. & Selig, S.
Hypomethylation of subtelomeric regions in ICF syndrome is associated with
abnormally short telomeres and enhanced transcription from telomeric regions.
Hum. Mol. Genet. 17, 2776–2789 (2008).
34. Deng, Z., Campbell, A. E. & Lieberman, P. M. TERRA, CpG methylation and
telomere heterochromatin: lessons from ICF syndrome cells. Cell Cycle 9, 69–74
(2010).
35. Yehezkel, S. et al. Characterization and rescue of telomeric abnormalities in ICF
syndrome type I fibroblasts. Front. Oncol. 3, 35 (2013).
36. Luke, B. & Lingner, J. TERRA: telomeric repeat-containing RNA. EMBO J. 28,
2503–2510 (2009).
37. Sagie, S. et al. Induced pluripotent stem cells as a model for telomeric
abnormalities in ICF type I syndrome. Hum. Mol. Genet. 23, 3629–3640 (2014).
38. Porro, A. et al. Functional characterization of the TERRA transcriptome at
damaged telomeres. Nat. Commun. 5, 5379 (2014).
39. Huertas, P. & Aguilera, A. Cotranscriptionally formed DNA:RNA hybrids
mediate transcription elongation impairment and transcription-associated
recombination. Mol. Cell 12, 711–721 (2003).
40. Diman, A. et al. Nuclear respiratory factor 1 and endurance exercise promote
human telomere transcription. Sci. Adv. 2 (2016).
41. Ginno, P. A., Lim, Y. W., Lott, P. L., Korf, I. & Chedin, F. GC skew at the 50 and
30 ends of human genes links R-loop formation to epigenetic regulation and
transcription termination. Genome Res. 23, 1590–1600 (2013).
42. Lim, Y. W., Sanz, L. A., Xu, X., Hartono, S. R. & Chedin, F. Genome-wide DNA
hypomethylation and RNA:DNA hybrid accumulation in Aicardi-Goutieres
syndrome. eLife 4, e08007 (2015).
43. Loomis, E. W., Sanz, L. A., Chedin, F. & Hagerman, P. J. Transcription-
associated R-loop formation across the human FMR1 CGG-repeat region. PLoS
Genet. 10, e1004294 (2014).
44. Maicher, A., Kastner, L., Dees, M. & Luke, B. Deregulated telomere
transcription causes replication-dependent telomere shortening and promotes
cellular senescence. Nucleic Acids Res. 40, 6649–6659 (2012).
45. Porro, A., Feuerhahn, S., Reichenbach, P. & Lingner, J. Molecular dissection of
telomeric repeat-containing RNA biogenesis unveils the presence of distinct
and multiple regulatory pathways. Mol. Cell Biol. 30, 4808–4817 (2010).
46. Flynn, R. L. et al. Alternative lengthening of telomeres renders cancer cells
hypersensitive to ATR inhibitors. Science 347, 273–277 (2015).
47. Flynn, R. L. et al. TERRA and hnRNPA1 orchestrate an RPA-to-POT1 switch
on telomeric single-stranded DNA. Nature 471, 532–536 (2011).
48. Arnoult, N., Van Beneden, A. & Decottignies, A. Telomere length regulates
TERRA levels through increased trimethylation of telomeric H3K9 and
HP1alpha. Nat. Struct. Mol. Biol. 19, 948–956 (2012).
49. Brambati, A., Colosio, A., Zardoni, L., Galanti, L. & Liberi, G. Replication and
transcription on a collision course: eukaryotic regulation mechanisms and
implications for DNA stability. Front. Genet. 6, 166 (2015).
50. Sollier, J. & Cimprich, K. A. Breaking bad: R-loops and genome integrity.
Trends Cell Biol. 25, 514–522 (2015).
51. Phan, A. T. Human telomeric G-quadruplex: structures of DNA and RNA
sequences. FEBS J. 277, 1107–1117 (2010).
52. Bah, A., Wischnewski, H., Shchepachev, V. & Azzalin, C. M. The telomeric
transcriptome of Schizosaccharomyces pombe. Nucleic Acids Res. 40, 2995–3005
(2012).
53. Helmrich, A., Ballarino, M., Nudler, E. & Tora, L. Transcription-replication
encounters, consequences and genomic instability. Nat. Struct. Mol. Biol. 20,
412–418 (2013).
54. Cusanelli, E. & Chartrand, P. Telomeric repeat-containing RNA TERRA:
a noncoding RNA connecting telomere biology to genome integrity. Front.
Genet. 6, 143 (2015).
55. Lalevee, S. & Feil, R. Long noncoding RNAs in human disease: emerging
mechanisms and therapeutic strategies. Epigenomics 7, 877–879 (2015).
56. Episkopou, H. et al. Alternative lengthening of telomeres is characterized by
reduced compaction of telomeric chromatin. Nucleic Acids Res. 42, 4391–4405
(2014).
57. Vera, E., Canela, A., Fraga, M. F., Esteller, M. & Blasco, M. A. Epigenetic
regulation of telomeres in human cancer. Oncogene 27, 6817–6833 (2008).
58. Tilman, G. et al. Subtelomeric DNA hypomethylation is not required for telomeric
sister chromatid exchanges in ALT cells. Oncogene 28, 1682–1693 (2009).
59. Lee, M. E., Rha, S. Y., Jeung, H. C., Chung, H. C. & Oh, B. K. Subtelomeric
DNA methylation and telomere length in human cancer cells. Cancer Lett. 281,
82–91 (2009).
60. Clynes, D. et al. Suppression of the alternative lengthening of telomere pathway
by the chromatin remodelling factor ATRX. Nat. Commun. 6, 7538 (2015).
61. Velasco, G. et al. Germline genes hypomethylation and expression define a
molecular signature in peripheral blood of ICF patients: implications for
diagnosis and etiology. Orphanet. J. Rare Dis. 9, 56 (2014).
62. Ofir, R., Wong, A. C., McDermid, H. E., Skorecki, K. L. & Selig, S. Position
effect of human telomeric repeats on replication timing. Proc. Natl Acad. Sci.
USA 96, 11434–11439 (1999).
63. Moyzis, R. K. et al. A highly conserved repetitive DNA sequence, (TTAGGG)n,
present at the telomeres of human chromosomes. Proc. Natl Acad. Sci. USA 85,
6622–6626 (1988).
64. Hanish, J. P., Yanowitz, J. L. & de Lange, T. Stringent sequence requirements
for the formation of human telomeres. Proc. Natl Acad. Sci. USA 91, 8861–8865
(1994).
65. Cerritelli, S. M. et al. Failure to produce mitochondrial DNA results in
embryonic lethality in Rnaseh1 null mice. Mol. Cell 11, 807–815 (2003).
66. Aronesty, E. Command-line tools for processing biological sequencing data.
https//github.com/ExpressionAnalysis/ea-utils (2011).
67. Langmead, B. & Salzberg, S. L. Fast gapped-read alignment with Bowtie 2. Nat.
Methods 9, 357–359 (2012).
68. Li, H. et al. The Sequence Alignment/Map format and SAMtools.
Bioinformatics 25, 2078–2079 (2009).
69. Zhang, Y. et al. Model-based analysis of ChIP-Seq (MACS). Genome Biol. 9,
R137 (2008).
70. Cesare, A. J. et al. Spontaneous occurrence of telomeric DNA damage response
in the absence of chromosome fusions. Nat. Struct. Mol. Biol. 16, 1244–1251
(2009).
Acknowledgements
We thank Harold Reithman for sharing unpublished subtelomeric sequences and to
Anabelle Decottignies for sharing the TERRA promoter and TSS prediction data
with us and for helpful advice and comments. We thank Dale Frank and Miriam
Gagliardi for helpful discussions and Daniel Kornitzer, Omer Schwartzman and Maty
Tzukerman for comments on the manuscript. Thanks to the BCF unit members, Rap-
paport Faculty of Medicine: Yaakov Sakoury and Amir Grau from the FACS unit, and
Liat Linde and Shimrat Mamrut from the genomic center for help in technical issues.
This research was supported by The Israel Science Foundation (grant no. 883/12,
to S. Selig), The Legacy Heritage Bio-Medical Program of the Israel Science
Foundation (grant no 657/15, to S. Selig) and The National Institutes of Health
(GM094299 to F.C.). S. Sagie is grateful to the Azrieli Foundation for the award
of an Azrieli Fellowship. S.R.H. is a Howard Hughes Medical Institute International
Student Research fellow.
Author contributions
S. Selig, S. Sagie and F.C. conceived and designed the experiments, S. Sagie, S. Selig, S.T.,
H.K., A.T.-G. and S.H. performed the experiments, S. Sagie, S. Selig, F.C., S.R.H. and S.T.
analysed and interpreted the data, S. Selig, S. Sagie and F.C. wrote the paper, S.T., S.R.H.,
C.F. and G.V. contributed to preparing the manuscript. C.F. and G.V. contributed
reagents.
Additional information
Supplementary Information accompanies this paper at http://www.nature.com/
naturecommunications
Competing financial interests: The authors declare no competing financial
interests.
Reprints and permission information is available online at http://npg.nature.com/
reprintsandpermissions/
How to cite this article: Sagie, S. et al. Telomeres in ICF syndrome cells are vulnerable to
DNA damage due to elevated DNA:RNA hybrids. Nat. Commun. 8:14015
doi: 10.1038/ncomms14015 (2017).
Publisher’s note: Springer Nature remains neutral with regard to jurisdictional claims in
published maps and institutional affiliations.
This work is licensed under a Creative Commons Attribution 4.0
International License. The images or other third party material in this
article are included in the article’s Creative Commons license, unless indicated otherwise
in the credit line; if the material is not included under the Creative Commons license,
users will need to obtain permission from the license holder to reproduce the material.
To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/
r The Author(s) 2017
ARTICLE NATURE COMMUNICATIONS | DOI: 10.1038/ncomms14015
12 NATURE COMMUNICATIONS | 8:14015 | DOI: 10.1038/ncomms14015 | www.nature.com/naturecommunications
